Stream Your Event | Partners | Speakers CART ITEMS: - | CHECKOUT

Dr. Andrew von Eschenbach: Modernizing the FDA

Watch Full Video | free previews

Commonwealth Club of California

Commonwealth Club

Info
Bio
Chapters
Preview
Zoom In

Dr. Andrew von Eschenbach on FDA Clinical Trials

04 min 46 sec

Add to Profile

Commissioner of the U.S. Food and Drug Administration Andrew von Eschenbach states the current clinical trials are "slow, laborious, and fraught with failure" and "subject patients to risky experimentation."

In response to this failure, Dr. von Eschenbach advocates the Sentinel Initiative - an electronic system which tracks drug performance to the benefit of public health.
Andrew von Eschenberg - The Source of Salmonella Tomatoes

02 min 50 sec

Add to Profile

Commissioner of the U.S. Food and Drug Administration Andrew von Eschenbach details the "CSI-like investigation" in ferreting out the source of Salmonella-tainted tomatoes.

After "identifying the culprit," the bacteria must be traced through an "enormously complex supply chain" to its source.

Considering the global complexity of the food system in which food is "mixed, mingled, shipped, sold" without regard to disease, Dr. von Eschenbach calls for a new regulatory body which prevents against further outbreaks.

This challenge, he says, calls for "new authorities, new information, and new scientific technologies."
Andrew von Eschenbach on the FDA Drug Approval Process

02 min 15 sec

Add to Profile

Commissioner of the U.S. Food and Drug Administration Andrew von Eschenbach is challenged to outline the FDA drug approval process in one minute.

He begins by describing the application process from lab to clinical trials.

The overarching questions, Dr. von Eschenbach asks of his drugs is "Is this safe? Is this effective? Do the benefits outweigh the risks?"
Watch Full Program

01 hr 04 min 39 sec

Add to Profile